Qualitative study to understand cost-effectiveness of AAOT v1

  • Research type

    Research Study

  • Full title

    Qualitative study to increase understanding of the cost-effectiveness of alcohol assertive outreach treatment (AAOT) for people who frequently attend hospital for alcohol-related reasons.

  • IRAS ID

    264767

  • Contact name

    Colin Drummond

  • Contact email

    colin.drummond@kcl.ac.uk

  • Sponsor organisation

    King's College London

  • Duration of Study in the UK

    0 years, 10 months, 1 days

  • Research summary

    Alcohol misuse places a significant burden on the NHS. Alcohol-related hospital admissions have doubled in the last ten years. Reducing alcohol-related admissions is a key public health priority in England. People who attend hospital frequently with alcohol-related problems are a relatively small subgroup but have multiple unplanned hospital attendances during a relatively short time period. They account for a disproportionately large use of NHS resources and therefore financial cost. Complex health and social support needs often prevent them from accessing or engaging with conventional addiction community treatment.

    Assertive outreach is a service model that was originally developed for people with severe mental illness. It may be a suitable approach for people who frequently attend hospital for alcohol-related reasons. It has a strong emphasis on proactive engagement with patients over an extended period, a patient-led agenda. Care coordinators have small caseloads and work in a multidisciplinary team that meets regularly.

    A randomised controlled trial is under way to test the effectiveness and cost-effectiveness of assertive outreach treatment delivered to people who frequently attend hospital for alcohol-related reasons. This qualitative study aims to increase the understanding of the factors underlying its cost-effectiveness through in-depth qualitative interviews with a small sample of participants from the trial.

    Participants from both the intervention arm (assertive outreach treatment) and the care as usual arm of the clinical trial will be asked about their experience of the treatment they received, whether their health and quality of life has changed over the 12 months, and if so, what they believe to be the reasons for that. They will also be asked whether their use of other services, particularly A&E and hospital admissions, has changed and if so, what they believe to be the reasons for that.

  • REC name

    Wales REC 4

  • REC reference

    19/WA/0227

  • Date of REC Opinion

    13 Aug 2019

  • REC opinion

    Favourable Opinion